{
    "clinical_study": {
        "@rank": "105860", 
        "acronym": "SonR-ECHO", 
        "arm_group": [
            {
                "arm_group_label": "SonR optimization", 
                "arm_group_type": "Active Comparator", 
                "description": "SonR optimization algorithm ON"
            }, 
            {
                "arm_group_label": "Standard of Care", 
                "arm_group_type": "No Intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "The main objective of the SONR-ECHO trial is to demonstrate that optimization of CRT\n      parameters by SonR technology is able to increase the rate of CRT-D responders, based on\n      significant LV reverse remodeling, as compared to Standard of Care settings.\n\n      This study will also evaluate the effectiveness of CRT-D SonR system as compared to Standard\n      of care (SoC) programming methods in providing appropriate LV filling, as expected from the\n      Ritter method."
        }, 
        "brief_title": "Clinical Assessment of the SonR Algorithm in the PARADYM RF SonR CRT-D by Echocardiography", 
        "condition": "Cardiac Resynchronization Therapy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Eligible for implantation of a CRT-D device according to published relevant ESC and\n             CCS guidelines ;\n\n          -  In Sinus Rhythm;\n\n          -  Have reviewed, signed and dated an informed consent\n\n        Exclusion Criteria:\n\n          -  Previous implant with a pacemaker, an Implantable Cardioverter-Defibrillator or a CRT\n             device (except upgrade from single chamber ICD with a fully functional defibrillation\n             lead  not under recall or surveillance);\n\n          -  Persistent atrial arrhythmias (or cardioversion for Atrial Fibrillation)  within the\n             past month;\n\n          -  Ventricular tachyarrhythmia secondary to reversible causes such as acute myocardial\n             infarction (MI), digitalis intoxication, drowning, electrocution, electrolyte\n             imbalance, hypoxia or sepsis, uncorrected at the time of the enrolment;\n\n          -  Incessant ventricular tachyarrhythmia;\n\n          -  Unstable angina, or acute MI, Coronary Artery Bypass-Grafting (CABG), or Percutaneous\n             Transluminal Coronary Angioplasty (PTCA) within the past 4 weeks;\n\n          -  Correctable valvular disease that is the primary cause of heart failure;\n\n          -  Mechanical heart valve or indication for valve repair or replacement;\n\n          -  Recent Cerebro-Vascular Accident (CVA) or Transient Ischemic Attack (TIA) (within the\n             previous 3 months);\n\n          -  Post heart transplant (patients who are waiting for a heart transplant are allowed in\n             the study);\n\n          -  Already included in another clinical study that could confound the results of this\n             study;\n\n          -  Life expectancy less than 1 year;\n\n          -  Inability to understand the purpose of the study;\n\n          -  Unavailability for scheduled follow-up or refusal to cooperate;\n\n          -  Sensitivity to 1 mg Dexamethasone Sodium Phosphate (DSP);\n\n          -  Age of less than 18 years;\n\n          -  Pregnancy;\n\n          -  Drug addiction or abuse;\n\n          -  Under guardianship"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "328", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01869062", 
            "org_study_id": "ICSY01"
        }, 
        "intervention": {
            "arm_group_label": "SonR optimization", 
            "intervention_name": "SonR optimization on", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "CRT", 
        "lastchanged_date": "June 4, 2013", 
        "location": {
            "contact": {
                "last_name": "Fran\u00e7ois Philippon"
            }, 
            "facility": {
                "address": {
                    "city": "Qu\u00e9bec", 
                    "country": "Canada", 
                    "state": "Quebec"
                }, 
                "name": "Institut universitaire de Cardiologie et Pneumologie de Qu\u00e9bec"
            }, 
            "investigator": {
                "last_name": "Fran\u00e7ois Philippon", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Clinical Assessment of the SonR Algorithm in the PARADYM RF SonR CRT-D by Echocardiography", 
        "other_outcome": {
            "measure": "Report LV remodeling from LVEDV decrease at M6 / baseline", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "overall_contact": {
            "email": "fran\u00e7ois.philippon@med.ulaval.ca", 
            "last_name": "Fran\u00e7ois Philippon"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "Belgium: Ethics Committee", 
                "France: Institutional Ethical Committee", 
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "Germany: Ethics Commission", 
                "Italy: Ethics Committee", 
                "Portugal : Ethics Committee", 
                "Canada: Ethics Committee"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "CRT-responders rate increase based on LVESV decrease at M6 / baseline", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01869062"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "A-wave truncation assessment at M6", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "source": "Sorin Group", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sorin Group", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor)", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}